The 5 most recent market catalysts affecting $CLMT, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 2, 2026
Corporate Catalyst
Bullish
Impact 55
HC Wainwright & Co. Maintains Buy on Calumet, Raises Price Target to $75
HC Wainwright & Co. analyst Amit Dayal has raised the price target for Calumet (CLMT) from $60 to $75 while maintaining a 'Buy' rating. This upgrade signals increased confidence fr…
Sep 1, 2026
Corporate Catalyst
Bullish
Impact 85
Calumet Announces New Flight Plan For MaxSAF Expansion At Montana Renewables
Calumet announced a revised 'flight plan' for its Montana Renewables MaxSAF expansion, dramatically cutting the remaining project capital from $1.2 billion to $137 million. This is…
Aug 25, 2026
Corporate Catalyst
Bullish
Impact 55
UBS Maintains Neutral on Calumet, Raises Price Target to $47
UBS analyst Manav Gupta maintained a 'Neutral' rating on Calumet (CLMT) but substantially increased the price target from $26 to $47. This action suggests that while UBS doesn't se…
Aug 12, 2026
Corporate Catalyst
Bullish
Impact 55
TD Cowen Maintains Hold on Calumet, Raises Price Target to $40
TD Cowen analyst Jason Gabelman maintained a 'Hold' rating on Calumet (CLMT) but raised the price target from $34 to $40. This action suggests that while the analyst doesn't see an…
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 92
Calumet Specialty Prods Q2 EPS $(1.09) Misses $(0.34) Estimate, Sales $1.445B Beat $1.082B Estimate
Calumet Specialty Products (CLMT) announced Q2 earnings with a substantial miss on EPS, reporting $(1.09) against an estimate of $(0.34), a 220.59% deviation. This indicates signif…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.